SLN
Silence Therapeutics
SLN
SLN
54 hedge funds and large institutions have $96.4M invested in Silence Therapeutics in 2025 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
11% less capital invested
Capital invested by funds: $108M → $96.4M (-$11.6M)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $6K
Holders
54
Holding in Top 10
2
Calls
–
Puts
$6K
Top Buyers
| 1 | +$518K | |
| 2 | +$409K | |
| 3 | +$141K | |
| 4 |
Goldman Sachs
New York
|
+$118K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$112K |
Top Sellers
| 1 | -$552K | |
| 2 | -$481K | |
| 3 | -$219K | |
| 4 |
SVCM
Saturn V Capital Management
Austin,
Texas
|
-$201K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$161K |
